Harrow, Inc. Common Stock (HROW) is a publicly traded Healthcare sector company. As of July 21, 2026, HROW trades at $44.78 with a market cap of $1.74B and a P/E ratio of -321.16. HROW moved +0.61% today. Year to date, HROW is -11.14%; over the trailing twelve months it is +23.85%. Its 52-week range spans $20.85 to $54.85. Analyst consensus is strong buy with an average price target of $66.67. Rallies surfaces HROW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for HROW shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $44.78 |
| Market Cap | $1.74B |
| P/E Ratio | -321.16 |
| EPS | $-0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $54.85 |
| 52-Week Low | $20.85 |
| Volume | 201.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $272.30M |
| Net Income | $-5.14M |
| Gross Margin | 75.05% |
7 analysts cover HROW: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $66.67.